Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Index01:13

Therapeutic Index

6.3K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.3K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

124
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
124
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

115
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
115
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

174
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
174
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

607
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
607
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

96
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
96

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the effect of communication skills training on communication apprehension in first year pharmacy students - A two-year study.

Currents in pharmacy teaching & learning·2020
Same author

Neuroleptic Malignant Syndrome Secondary to Metoclopramide Use in an Elderly Gastroenterologic Surgery Patient.

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2017
Same author

Pharmacy services after a tank car derailment and toxic chemical release in Blount County, Tennessee.

Journal of the American Pharmacists Association : JAPhA·2016
Same author

An Assessment of State Board of Pharmacy Legal Documents for Public Health Emergency Preparedness.

American journal of pharmaceutical education·2016
Same author

Civil War pharmacy: historical parallels and implications for disaster preparedness.

Pharmaceutical historian·2014
Same author

Pharmacists' Roles in Post-September 11th Disasters: A Content Analysis of Pharmacy Literature.

Journal of pharmacy practice·2013

Related Experiment Video

Updated: Dec 23, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K

An Exploratory Analysis of PharmD Program Value Using the Tuition: Licensure Index.

Heath Ford1

  • 1South College School of Pharmacy, Knoxville, Tennessee.

American Journal of Pharmaceutical Education
|April 22, 2020
PubMed
Summary

The new Tuition: Licensure Index (TLI) shows that in-state public Doctor of Pharmacy (PharmD) programs offer better value than private ones. Consider tuition and licensure pass rates when choosing a PharmD program.

Keywords:
educational measurementpharmacy educationpharmacy licensureprogram evaluation

More Related Videos

Estimating the Yield of Compounds on the TLC Plate via the Blue-LED Illumination Technique
06:14

Estimating the Yield of Compounds on the TLC Plate via the Blue-LED Illumination Technique

Published on: October 6, 2022

2.2K
Learning Modern Laryngeal Surgery in a Dissection Laboratory
07:30

Learning Modern Laryngeal Surgery in a Dissection Laboratory

Published on: March 18, 2020

8.6K

Related Experiment Videos

Last Updated: Dec 23, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K
Estimating the Yield of Compounds on the TLC Plate via the Blue-LED Illumination Technique
06:14

Estimating the Yield of Compounds on the TLC Plate via the Blue-LED Illumination Technique

Published on: October 6, 2022

2.2K
Learning Modern Laryngeal Surgery in a Dissection Laboratory
07:30

Learning Modern Laryngeal Surgery in a Dissection Laboratory

Published on: March 18, 2020

8.6K

Area of Science:

  • Pharmacy Education
  • Health Economics

Background:

  • Evaluating the financial value of Doctor of Pharmacy (PharmD) programs is crucial for prospective students.
  • Traditional metrics do not fully capture the return on investment for pharmacy education.

Purpose of the Study:

  • To introduce and assess the Tuition: Licensure Index (TLI) as a novel metric for evaluating PharmD program value.
  • To compare the value of different PharmD program types (public vs. private, traditional vs. accelerated) using the TLI.

Main Methods:

  • The TLI was calculated as a ratio of program tuition to licensure examination pass rates (NAPLEX and Multistate Pharmacy Jurisprudence Examination).
  • In-state and out-of-state tuition variations were analyzed (TLI-Nᵢ and TLI-Nₒ).
  • Data from the 2018 cohort, including total program tuition and NAPLEX pass rates, were sourced from public records.

Main Results:

  • A significant difference in the in-state TLI (TLI-Nᵢ) was observed between public and private PharmD programs, with public programs showing greater value.
  • No significant differences in the out-of-state TLI (TLI-Nₒ) were found between public and private programs.
  • Differences in TLI-Nᵢ between traditional and accelerated PharmD programs were not statistically significant.

Conclusions:

  • In-state public PharmD programs may offer superior financial value compared to private institutions.
  • Prospective students should utilize the TLI framework, considering both tuition costs and licensure examination success rates, when selecting a PharmD program.